Package Leaflet: Information for the User
Naramig 2.5 mg Film-Coated Tablets
Naratriptan
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Naramig tablets contain naratriptan (hydrochloride), which belongs to a group of medicines called triptans (also known as 5-HT1 receptor agonists).
Naramig tablets are used to treat migraine headaches.
Migraine symptoms may be caused by temporary widening of blood vessels in the head. It is thought that Naramig works by reversing this widening, which helps to relieve the headache and other symptoms of migraine, such as nausea and vomiting and sensitivity to light and sound.
Do not take Naramig:
If you are in any of these situations:
→Tell your doctor and do not take Naramig.
Warnings and precautions
Consult your doctor or pharmacist before taking Naramig.
If you have any risk factors:
On very rare occasions, people have had serious heart problems after taking Naramig, even though they had no history of heart disease.
If you are in any of the above situations, you may have a greater risk of heart disease. Therefore:
→Tell your doctor so that your heart function can be checkedbefore starting treatment with Naramig.
If you are allergic to antibiotics called sulphonamides
If so, you may also be allergic to Naramig. If you are allergic to an antibiotic but are not sure if it is a sulphonamide:
→Tell your doctor or pharmacist before taking Naramig.
If you take Naramig frequently
Taking Naramig too frequently can make your headaches worse.
→Tell your doctorif you are in this situation. They may advise you to stop taking Naramig.
If you feel pain or tightness in your chest after taking Naramig
These effects can be intense but are usually temporary. If they do not go away quickly or get worse:
→See a doctor immediately. Section 4 of this leaflet has more information on this side effect.
If you are taking antidepressants called SSRIs (Selective Serotonin Reuptake Inhibitors) or SNRIs (Serotonin and Noradrenaline Reuptake Inhibitors)
→Tell your doctor or pharmacist before taking Naramig.
Using Naramig with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including herbal remedies or medicines bought without a prescription.
Some medicines must not be taken with Naramig and others may cause side effects if taken with Naramig. Tell your doctor if you are taking:
Driving and using machines
Naramig contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars:
→Consult your doctor beforetaking this medicine.
This medicine contains less than 23 mg of sodium (1mmol) per tablet; this is, essentially “sodium-free”.
Take Naramig only after your migraine headache has started
Do not take Naramig to prevent an attack
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are not sure, ask your doctor or pharmacist again.
What dose should you take
Naramig is not recommended for children under 18 years old or adults over 65 years old.
When to take your dose
If your symptoms come back
If you do not get relief with the first dose
If Naramig does not provide you with any relief:
?Ask your doctor or pharmacist.
If you take more Naramig than you should
If you take more Naramig than you should, you may feel unwell. If you have taken more than 2 tablets in 24 hours:
?Tell your doctor or call the Toxicology Information Service, telephone 91.562.04.20, stating the medicine and the amount taken.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Allergic reaction: see a doctor immediately(may affect up to 1 in 1,000 people)
If you experience any of these symptoms soon after taking Naramig:
→Do not take any more tablets and contact a doctor immediately.
Common side effects(may affect up to 1 in 10 people)
If you experience any of these side effects:
→Tell your doctor or pharmacist.
Uncommon side effects(may affect up to 1 in 100 people)
If these side effects continue or get worse, especially chest pain:
→Seek medical attention immediately. In a small number of people, these symptoms can be caused by a heart attack.
Other uncommon side effects include:
If you experience these side effects:
→Tell your doctor or pharmacist.
Rare side effects(may affect up to 1 in 1,000 people)
If you experience these side effects:
→Tell your doctor or pharmacist.
Very rare side effects(may affect up to 1 in 10,000 people)
If you experience these side effects:
→Tell your doctor or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use, www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton (EXP). The expiry date refers to the last day of the month shown.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Naramig contains
The active substanceis naratriptan (2.5 mg), as hydrochloride.
The other ingredientsof the tablet core are: microcrystalline cellulose, anhydrous lactose, sodium croscarmellose and magnesium stearate. The other ingredients of the tablet coating are: hypromellose, titanium dioxide (E171), triacetin, yellow iron oxide (E172), indigo carmine (indigo carmine, E132).
Appearance and packaging
Naramig tablets are green, film-coated, D-shaped and engraved with GX CE5 on one side. They are available in child-resistant blister packs containing 2, 4, 6 or 12 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holderGlaxo, S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Tel: +34 900 202 700
ManufacturerDelpharm Poznan Spólka Akcyjna ul. Grunwaldzka 189 60-322 Poznan Poland
This medicine is authorised in the Member States of the European Economic Area under the following names:
Belgium Naramig
Finland Naramig
France Naramig
Germany Naramig
Greece Naramig
Luxembourg Naramig
Netherlands Naramig
Portugal Naramig
Spain Naramig
Sweden Naramig
Date of last revision of this leaflet:June 2020.
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of NARAMIG 2.5 mg FILM-COATED TABLETS in October, 2025 is around 19.14 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for NARAMIG 2.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.